Consensus Ryvu Therapeutics S.A.

Equities

Market Closed - Warsaw S.E. Other stock markets 11:55:46 2024-05-06 am EDT			5-day change	1st Jan Change
51.8 ^PLN	+6.58%		+6.04%	-9.91%

Mar. 13	Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting	CI

f52e4957471a.y6Q0-ELrpu9bPJiEWX2JJ2toI2eOuSkND9-alCJuvCo.-9VyrCff4qZsX-DOHhPQVCExaQPPlF1XeYzbo2ko1h-pkkecO6rFpGNLzQ~4e12cd6cb6201bbc5a832dd796f12e1c

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

51.8 PLN

Average target price

73.12 PLN

Spread / Average Target

+41.17%

High Price Target

80 PLN

Spread / Highest target

+54.44%

Low Price Target

64 PLN

Spread / Lowest Target

+23.55%

Trading Rating

Investor Rating

ESG Refinitiv